Renaissance Technologies - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$959
-51.8%
51,300
-52.7%
0.00%
-66.7%
Q1 2023$1,991
+211.1%
108,500
+235.9%
0.00%
+200.0%
Q4 2022$640
-99.9%
32,300
+8.8%
0.00%0.0%
Q3 2022$715,000
-28.6%
29,700
-34.7%
0.00%0.0%
Q1 2022$1,001,000
+44.2%
45,500
+140.7%
0.00%0.0%
Q4 2021$694,000
-41.5%
18,900
-50.5%
0.00%
-50.0%
Q3 2021$1,186,000
+441.6%
38,200
+244.1%
0.00%
Q4 2020$219,00011,1000.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$49,189,39517.79%
Euclidean Capital LLC 432,900$7,943,7156.97%
GREAT POINT PARTNERS LLC 1,355,151$24,867,0214.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 875,984$16,074,3063.02%
Trustees of Columbia University in the City of New York 80,580$1,478,6432.64%
Perceptive Advisors 2,291,608$42,051,0071.24%
Cormorant Asset Management, LP 650,000$11,9280.79%
Alphabet Inc. 540,270$9,913,9550.55%
Redmile Group, LLC 688,132$12,627,2220.55%
Orbimed Advisors 1,251,070$22,957,1350.45%
View complete list of RAPT THERAPEUTICS INC shareholders